Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$561,124,228
+$154,644,239 QoQ
Shares Held
11,704,719
+5.8% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#4
of 1,348 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. NVO ranks #9 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in NVO
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $561,124,228 | 11,704,719 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $406,479,989 | 11,060,680 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $492,938,770 | 9,688,262 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $269,236,203 | 4,851,977 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $428,149,281 | 6,203,264 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $369,744,806 | 5,324,666 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $545,807,050 | 6,345,118 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,141,099,605 | 9,583,435 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,356,567,272 | 9,503,764 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,102,856,104 | 8,589,222 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $803,411,941 | 7,766,186 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $748,519,409 | 8,230,915 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $619,395,423 | 3,827,445 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $602,434,017 | 3,785,560 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $31,731,274 | 234,456 | Shares | Sole | 2023-02-14 | |
| 2020-03-31 | $21,479,239 | 356,798 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||